The Delhi High Court declined interim relief to JNTL Consumer Health, Johnson & Johnson’s Indian arm, to sell its remaining ORSL stock, upholding the FSSAI order against misleading branding
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
